Optimal Management of Cancer Treatment-Induced Bone Loss: Considerations for Elderly Patients

ISSN： 1170-229X

Source： Drugs & Aging, Vol.28, Iss.11, 2011-11, pp. : 867-883

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Management of Patients With Non-Ulcer Dyspepsia: Considerations for the Treatment of the Elderly

By Asante M.A.

Drugs & Aging, Vol. 18, Iss. 11, 2001-01 ,pp. : 819-826

Adis International

Access to resources Recommend Favorite

Emerging drugs for the management of cancer treatment induced bone loss

By Bertoldo Francesco Pancheri Serena Zenari Sonia Boldini Stefania

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 323-342

Informa Healthcare

Access to resources Recommend Favorite

Background to and Management of Treatment-Related Bone Loss in Prostate Cancer

By Berruti A.

Drugs & Aging, Vol. 19, Iss. 12, 2002-01 ,pp. : 899-910

Adis International

Access to resources Recommend Favorite

Antiepileptics increase bone loss in elderly patients?

Reactions Weekly, Vol. 1, Iss. 1012, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Early Breast Cancer in the Elderly: Assessment and Management Considerations

By Albrand Gilles

Drugs & Aging, Vol. 25, Iss. 1, 2008-01 ,pp. : 35-45

Adis International

Access to resources Recommend Favorite